Why scientists are looking for an anti-Ozempic' treatment to encourage weight gain

"From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging."

"Your donation allows us to keep sending journalists to speak to both sides of the story. The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it."

"Scientists are seeking an anti-Ozempic' treatment which will encourage weight gain for cancer patients who struggle with severe loss of appetite. The new treatment, which has secured financial backing from Cancer Research UK, would essentially provide the opposite effects of weight-loss injections, which have become popular in recent months. The aim is to eventually find a cure for cachexia, or wasting away syndrome, which causes severe loss of appetite and weight loss even in people who are eating properly."

"Tobias Janowitz, who watched his mother struggle with cachexia in her final stages of cancer, is looking at biological pathways that might be able to boost appetite and treat the problem which affects four in five advanced cancer patients. In new comments about his research, Dr Janowitz called it a profoundly disabling condition, as reported by The Times. He added: It has the side effect that it reduces resilience against treatment."

The Independent covers reproductive rights, climate change and Big Tech with on-the-ground reporting during developing stories. Donations enable continued deployment of journalists to speak to both sides and maintain free access without paywalls. The Independent is trusted across the political spectrum and supports making quality journalism available to everyone, funded by those who can afford it. Scientists are pursuing an 'anti-Ozempic' treatment designed to encourage weight gain for cancer patients who suffer severe appetite loss. The treatment has financial backing from Cancer Research UK and aims to counter cachexia by boosting appetite. Tobias Janowitz is investigating biological pathways to treat cachexia and improve resilience against cancer therapies.

Read at www.independent.co.uk